• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 2.5/18; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOTRONIK AG, BUELACH, SWITZERLAND ORSIRO (US) 2.5/18; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 401748
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Thrombosis (2100)
Date of Event 10/15/2019
Type of Reportable Event Serious Injury
Event or Problem Description
An orsiro drug-eluting stent system was chosen to treat a calcified lesion with 85 percent stenosis degree.4 hours after implantation patient experienced chest pain.A stent thrombosis was detected.
 
Additional Manufacturer Narrative
Neither the complaint instrument nor the angiographic material was available for analysis.Therefore no technical investigation on the subject could be performed.The production documentation was reviewed to establish whether a deviation from the manufacturing process could be the cause for the reported event.Review of the production documentation confirmed that the instrument was manufactured according to specifications and passed all in-process and final inspections.Based on the conducted investigations no manufacturing related root cause was determined.The physician determined that the stent thrombosis was not stent related since the ostial lesion was probably not completely covered.The root cause for the complaint event is therefore most likely related to external factors.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ORSIRO (US) 2.5/18
Common Device Name
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BIOTRONIK AG, BUELACH, SWITZERLAND
ackerstrasse 6
buelach CH-81 80
CH  CH-8180
MDR Report Key9255568
Report Number1028232-2019-04759
Device Sequence Number2054431
Product Code NIQ
UDI-Device Identifier07640130439030
UDI-Public07640130439030
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P170030
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2019
Reporter Type Manufacturer
Report Source company representative,user f
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 10/18/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/08/2020
Device Model Number401748
Device Catalogue NumberSEE MODEL NO.
Device Lot Number10185791
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 10/18/2019
Supplement Date Received by Manufacturer12/10/2019
Initial Report FDA Received Date10/30/2019
Supplement Report FDA Received Date12/10/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Hospitalization; Required Intervention;
Patient Age70 YR
-
-